The CDC estimates that depression now impacts one in six American adults. After the newest numbers, ABC15 gets an up close ...
For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...
Spruce Biosciences discontinues tildacerfont trials for CAH as CAHmelia-204 misses primary endpoint and CAHptain-205 shows ...
The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...
Relmada is now scrapping Reliance II, plus another phase 3 trial called Relight, which was assessing REL-1017 as an add-on ...